| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.25B | $2.15B | $1.94B |
| YoY Revenue Growth % | +4.9% | +10.9% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.04B | $870.0M | $916.0M |
| Operating Margin % | 46.0% | 40.5% | 47.2% |
| Net Income (GAAP) | $654.0M | $667.0M | $625.0M |
| EBITDA (Normalized) | $1.12B | $947.4M | $985.8M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.29B | $1.34B | $1.64B |
| Capital Expenditures (CapEx) | $101.5M | $96.8M | $87.3M |
| Free Cash Flow (FCF) | $1.19B | $1.25B | $1.55B |
| FCF Margin % | 52.6% | 58.1% | 80.0% |
| Return on Invested Capital (ROIC %) | 95.0% | 95.0% | 24.4% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $1.52B | $2.10B | $1.15B |
| Total Stockholders' Equity | $4.95B | $4.00B | $2.35B |